SEC Form 4 · accession 0000899243-16-020198
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael N Needle
Officer — Chief Medical Officer
Period of report
May 13, 2016
Accepted (ET)
May 17, 2016 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 13, 2016 | A | 51,813 | — | A | 51,813 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrants (right to buy)F1,F2,F3 | $1.00 | May 13, 2016 | A | 51,813 | A | — | — | Common Stock | 51,813 | 51,813 | D |
Explanation of responses
- F1The reported securities are included within 51,813 Units purchased by the reporting person for $0.965 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- F2The warrants are immediately exercisable upon issuance.
- F3The warrants expire five years from their date of issuance.